Member Comments are provided by individuals and reflect their personal opinions only. Under NO circumstances should you act on any advice or opinion posted in this forum. ALWAYS check with your personal physician before taking any action regarding your health! MedHelp International and our partners, sponsors and affiliates have no obligation to monitor any comments posted on this site, or the content and/or accuracy of such exchanges. MedHelp International does not endorse the views of any user.
Dear moneu: TamoxifenTamoxifen Tamoxifen citrate is used in womenWomen's way whose cancers are ER/PR positive (estrogenHormone replacement therapy receptor/progesterone receptor). It is used to reduce the chance of recurrence both locally and distantly as well as reduce the risk of developing a contralateral (opposite breast) breast cancer. Tamoxifen can also be used to reduce the risk of developing breast cancer in women who are at high risk.
I believe tamoxifen has been superceded by Arimidex - after my diagnosis of invasive ductal cancer and chemotherapy I was switched after 2 months of tamoxifen ( in 2004) to Arimidex, which I believe has a much better prognosis for recurrence than tamoxifen - that is if you are ER+.
It is my understanding (and I could be wrong) that Tamoxifen is still used instead of Arimidex depending on your menstrual status. Tamoxifen for women who are ER/PR+ and have not gone through menopause and Arimidex for ER/PR+ for women who have undergone menopause.
Twocapes is correct in the use of Tamoxifen and Arimidex. Right now Arimidex and Femara are not being given to premenopausal women. I was on Tamoxifen for 5 years, diagnosed with bc on the other side from the first bc and am now on Femara.